Lantheus Holdings (LNTH) Gross Margin Growth (3y) (2017 - 2026)

Lantheus Holdings (LNTH) Gross Margin Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 631.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 106.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -675.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 7,053.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 33.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -344.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -37,361.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -1,517.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 3,557.00
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 622.00

Historic Data

Download Data
DateValue
Mar 31, 2026 3,557.00
Dec 31, 2025 -431.00
Sep 30, 2025 -371.00
Jun 30, 2025 206.00
Mar 31, 2025 198.00
Dec 31, 2024 1,885.00
Sep 30, 2024 2,213.00
Jun 30, 2024 1,930.00
Mar 31, 2024 2,102.00
Dec 31, 2023 149,141.00
Sep 30, 2023 2,154.00
Jun 30, 2023 2,383.00
Mar 31, 2023 -1,627.00
Dec 31, 2022 1,364.00
Sep 30, 2022 1,313.00
Jun 30, 2022 969.00
Mar 31, 2022 1,083.00
Dec 31, 2021 -613.00
Sep 30, 2021 -869.00
Jun 30, 2021 -564.00